Veltiro 100mg Injection: Effective Medication for Your Needs

Veltiro 100mg Injection

Active constituent: Rituximab.

Uses:

• Non-Hodgkin’s lymphoma (cancer affecting white blood cells called B-lymphocytes).
• Chronic lymphocytic leukemia (a common form of cancer that affects B-cells).
• Rheumatoid arthritis (a type of disease where the immune system attacks the body cells of its own joints) in combination with methotrexate in adults.
• Granulomatosis with polyangiitis or microscopic polyangiitis (inflammation of blood vessels that mainly affects the lungs and kidneys) in adults and children 2 years of age and older.
• Pemphigus vulgaris (an autoimmune condition that causes painful blisters on the skin and lining of the mouth, throat, nose, and genitals).

Class of medications: Anti-CD20 monoclonal antibodies.

Contraindications:

• Do not take this injection if you are allergic to rituximab or any other ingredients of this medicine.
• Do not take if you have a weak immune system.
• Do not take if you have any severe active infection.
• Inform your physician if you have heart disease, heart failure, or breathing problems before initiating the treatment.
• Talk with your doctor if you have ever had a hepatitis B infection.
• Pregnancy and breastfeeding are not recommended when you are taking this injection.

Common side effects:

• Infection of the blood.
• Reduced red blood cells.
• Dizziness.
• Swelling in the face and body.
• Itchy skin.
• Diarrhea.
• Increased sweating.
• Low or high blood pressure.

Severe side effects:

• Increased or decreased blood pressure.
• Chest pain.
• Hypersensitivity reactions.
• Hepatitis B viral infection.
• Memory loss, trouble thinking, difficulty in walking.

Administration:

• Should only be administered by a trained doctor or nurse.
• Do not self-administer the injection.
• Before giving Veltiro 100mg injection, you will be given other medications (pre-medication) to reduce the possible side effects.
• Your doctor will decide the dose and duration of your treatment based on the disease severity and other factors.
• It will be given as an intravenous infusion, and you will be monitored carefully for any unwanted side effects.

Safety advices:

• Pregnancy: Veltiro 100mg injection is unsafe to administer in pregnant women because it may affect the fetus.
• Breastfeeding: Breastfeeding is not recommended in patients taking Veltiro 100mg injection.
• Lungs: Consult your doctor if you have any lung diseases before starting the treatment.
• Liver: Consult your doctor if you have or ever had liver disease or hepatitis B infection before starting the treatment.
• Alcohol: Stop consuming alcohol if you are taking this medicine.
• Driving: Caution is required while driving and operating machinery when you take Veltiro 100mg injection because it may cause dizziness, sleepiness, tiredness, and risk of falling.

FAQs:

1. What are the special precautions I should be aware of before starting treatment with Veltiro 100mg injection?

   • Inform your doctor about your pre-existing conditions (heart, kidney, liver, hepatitis B, or lung disease) and vaccination history.
   • It is necessary to consult a doctor if you are taking medicines for blood pressure.

2. Can Veltiro 100mg injection suppress the immune system?

   • Yes, Veltiro 100mg injection can suppress the immune system, and the chances of catching an infection are high.

3. What are Veltiro 100mg infusion-related reactions?

   • Infusion reactions occur during or within 24 hours after administering Veltiro 100mg injection. The symptoms are fever, chills, cough, itchy skin, nausea, vomiting, flushing, increased heart rate, and discomfort in the throat.

4. What will be the most important thing to monitor during Veltiro 100mg injection?

   • Your healthcare professional will monitor you carefully for unwanted side effects during the Veltiro 100mg injection. You will be monitored for heart failure, increased blood pressure, or breathing failure.

5. Is weight gain a side effect of Veltiro 100mg injection?

   • Weight gain has been reported in patients treated with Veltiro 100mg injection for non-Hodgkin’s lymphoma.

Fact box:

• Molecule name: Rituximab.
• Therapeutic class:
  • Antineoplastics.
  • DMARDs.
• Pharmacological class: Anti-CD20 monoclonal antibodies.
• Indications:
  • Non-Hodgkin’s lymphoma.
  • Chronic lymphocytic leukemia (CLL).
  • Rheumatoid Arthritis.
  • Granulomatosis with polyangiitis or microscopic polyangiitis.
  • Pemphigus vulgaris.

Tags: Veltiro, Injection, 100mg, Medical, Pharmaceuticals, Healthcare, Medicine, Drug, Treatment